These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 21430027

  • 1. Aberrant expression of thyroid hormone receptor beta isoform may cause inappropriate secretion of TSH in a TSH-secreting pituitary adenoma.
    Tagami T, Usui T, Shimatsu A, Beniko M, Yamamoto H, Moriyama K, Naruse M.
    J Clin Endocrinol Metab; 2011 Jun; 96(6):E948-52. PubMed ID: 21430027
    [Abstract] [Full Text] [Related]

  • 2. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.
    Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, Oldfield EH, Yen PM.
    Mol Endocrinol; 2001 Sep; 15(9):1529-38. PubMed ID: 11518802
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A case of TSH-secreting pituitary adenoma with cyclic fluctuations in serum TSH levels.
    Okuma H, Hashimoto K, Ohashi T, Mihara M, Minami I, Izumiyama H, Sasaki S, Inoshita N, Nishioka H, Yamada S, Yoshimoto T.
    Endocr J; 2018 Jul 28; 65(7):737-746. PubMed ID: 29695647
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.
    Sanno N, Teramoto A, Matsuno A, Takekoshi S, Osamura RY.
    J Clin Endocrinol Metab; 1995 Aug 28; 80(8):2518-22. PubMed ID: 7543115
    [Abstract] [Full Text] [Related]

  • 14. An unliganded thyroid hormone beta receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis.
    Furumoto H, Ying H, Chandramouli GV, Zhao L, Walker RL, Meltzer PS, Willingham MC, Cheng SY.
    Mol Cell Biol; 2005 Jan 28; 25(1):124-35. PubMed ID: 15601836
    [Abstract] [Full Text] [Related]

  • 15. Clinical and molecular features of a TSH-secreting pituitary microadenoma.
    Usui T, Izawa S, Sano T, Tagami T, Nagata D, Shimatsu A, Takahashi JA, Naruse M.
    Pituitary; 2005 Jan 28; 8(2):127-34. PubMed ID: 16379036
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A challenging TSH/GH co-secreting pituitary adenoma with concomitant thyroid cancer; a case report and literature review.
    Yoon JH, Choi W, Park JY, Hong AR, Kim SS, Kim HK, Kang HC.
    BMC Endocr Disord; 2021 Aug 30; 21(1):177. PubMed ID: 34461869
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.